VitaNova Life Sciences annual operating income
2018
2019
2020
2021
2022
2023
2024
2025
2026
VitaNova Life Sciences Operating Income Growth & History (VNOV)
VitaNova Life Sciences's operating income was $3,601 for fiscal 2026.
View full VitaNova Life Sciences company overviewVitaNova Life Sciences annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-30 | $3,601 | −$1.2M | −99.70% |
| 2025 | 2025-04-30 | $1.2M | $1.0M | +487.62% |
| 2024 | 2024-04-30 | $205,629 | $229,856 | — |
| 2023 | 2023-04-30 | −$24,227 | −$10,860 | — |
| 2022 | 2022-04-30 | −$13,367 | $38,727 | — |
| 2021 | 2021-04-30 | −$52,094 | $20,240 | — |
| 2020 | 2020-04-30 | −$72,334 | −$523 | — |
| 2019 | 2019-04-30 | −$71,811 | −$23,162 | — |
| 2018 | 2018-04-30 | −$48,649 | — | — |
VitaNova Life Sciences quarterly operating income
Q3.18
Q3.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q1.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-04-30 | −$109,860 | −$1.2M | — |
| Q3 2026 | 2026-01-31 | $46,731 | −$62,143 | −57.08% |
| Q2 2026 | 2025-10-31 | $99,170 | $36,570 | +58.42% |
| Q1 2026 | 2025-07-31 | −$32,440 | $12,974 | — |
| Q4 2025 | 2025-04-30 | $1.1M | $849,571 | +365.12% |
| Q3 2025 | 2025-01-31 | $108,874 | $102,926 | +1730.43% |
| Q2 2025 | 2024-10-31 | $62,600 | $71,355 | — |
| Q1 2025 | 2024-07-31 | −$45,414 | −$21,167 | — |
| Q4 2024 | 2024-04-30 | $232,683 | — | — |
| Q3 2024 | 2024-01-31 | $5,948 | — | — |
| Q2 2024 | 2023-10-31 | −$8,755 | — | — |
| Q1 2024 | 2023-07-31 | −$24,247 | −$26,381 | — |
| Q1 2023 | 2022-07-31 | $2,134 | $12,620 | — |
| Q2 2022 | 2021-10-31 | −$29,991 | −$17,606 | — |
| Q1 2022 | 2021-07-31 | −$10,486 | $761 | — |
| Q4 2021 | 2021-04-30 | −$25,563 | $774 | — |
| Q3 2021 | 2021-01-31 | −$2,899 | $3,695 | — |
| Q2 2021 | 2020-10-31 | −$12,385 | $7,134 | — |
| Q1 2021 | 2020-07-31 | −$11,247 | $8,637 | — |
| Q4 2020 | 2020-04-30 | −$26,337 | −$15,108 | — |
| Q3 2020 | 2020-01-31 | −$6,594 | $30,102 | — |
| Q2 2020 | 2019-10-31 | −$19,519 | −$11,459 | — |
| Q1 2020 | 2019-07-31 | −$19,884 | −$4,058 | — |
| Q4 2019 | 2019-04-30 | −$11,229 | — | — |
| Q3 2019 | 2019-01-31 | −$36,696 | −$35,466 | — |
| Q2 2019 | 2018-10-31 | −$8,060 | −$13,840 | — |
| Q1 2019 | 2018-07-31 | −$15,826 | — | — |
| Q3 2018 · Jan 31 | 2018-01-31 | −$1,230 | — | — |
| Q3 2018 · Oct 31 | 2017-10-31 | $5,780 | — | — |
VitaNova Life Sciences operating income trends
Over the last five fiscal years, VitaNova Life Sciences's operating income increased from −$52,094 to $3,601, a change of $55,695. The latest reported quarter, Q4 2026, shows −$109,860.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review VitaNova Life Sciences source filings ↗